🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/11/2014 5,78 5,89 5,65 5,82 +0,69% 4,15% 1.554.800
26/11/2014 5,80 5,93 5,73 5,78 -1,03% 3,45% 1.881.100
25/11/2014 6,20 6,20 5,71 5,84 -5,27% 7,90% 4.667.800
24/11/2014 5,90 6,18 5,90 6,17 +4,49% 4,75% 2.278.600
21/11/2014 5,85 5,98 5,72 5,90 +2,79% 4,44% 1.841.300
20/11/2014 5,60 5,82 5,55 5,74 +3,42% 4,82% 2.138.200
19/11/2014 5,93 6,00 5,52 5,55 -6,72% 8,09% 3.097.200
18/11/2014 5,92 6,06 5,88 5,95 +0,17% 3,04% 1.602.600
17/11/2014 6,02 6,12 5,85 5,94 -1,66% 4,49% 1.449.100
14/11/2014 6,20 6,25 5,82 6,04 -2,89% 6,87% 2.585.200
13/11/2014 6,52 6,60 6,20 6,22 -4,75% 6,13% 1.892.900
12/11/2014 6,40 6,79 6,38 6,53 +0,46% 6,41% 2.255.600
11/11/2014 6,36 6,57 6,23 6,50 +4,67% 5,35% 3.239.900
10/11/2014 6,40 6,50 6,13 6,21 +2,48% 5,78% 5.049.800
07/11/2014 6,25 6,25 5,84 6,06 -3,89% 6,54% 6.273.300
06/11/2014 6,18 6,45 6,18 6,31 +1,86% 4,37% 1.737.100
05/11/2014 6,48 6,53 6,16 6,19 -3,43% 5,79% 1.765.600
04/11/2014 6,51 6,55 6,17 6,41 -1,69% 5,87% 1.473.400
03/11/2014 6,52 6,72 6,42 6,52 +0,00% 4,60% 1.320.100
31/10/2014 6,96 6,98 6,32 6,52 -3,12% 9,48% 2.971.200
30/10/2014 6,61 6,84 6,59 6,73 +0,45% 3,78% 1.491.500
29/10/2014 6,87 6,88 6,55 6,70 -2,47% 4,85% 1.922.500
28/10/2014 7,02 7,13 6,82 6,87 -1,29% 4,42% 2.134.500
27/10/2014 7,11 7,20 6,76 6,96 -2,79% 6,19% 1.436.800
24/10/2014 6,97 7,22 6,92 7,16 +3,47% 4,30% 3.215.600
23/10/2014 6,86 7,31 6,76 6,92 +2,52% 8,02% 3.334.300
22/10/2014 6,91 7,12 6,72 6,75 -0,74% 5,79% 1.771.500
21/10/2014 6,57 6,95 6,46 6,80 +3,50% 7,46% 1.977.200
20/10/2014 6,42 6,73 6,27 6,57 +1,86% 7,17% 1.771.300
17/10/2014 7,20 7,32 6,25 6,45 -8,12% 14,86% 5.254.000